Triomics nabs $22M to bring oncology-specific AI to cancer centers
Quick Take
Triomics has secured $22 million in Series B funding led by Battery Ventures to enhance oncology-specific AI solutions for cancer centers. This investment aims to improve diagnostic accuracy and treatment personalization in oncology, ultimately benefiting patients and healthcare providers.
Key Points
- Funding led by Battery Ventures to support oncology-specific AI development.
- Investment aims to enhance diagnostic accuracy in cancer treatment.
- Focus on personalizing treatment plans for better patient outcomes.
- Triomics targets cancer centers with advanced AI solutions.
Article Excerpt
From source RSS / original summaryThe Series B round was led by Battery Ventures.
Reader Mode unavailable (could not extract clean content).
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from TechCrunch
See more →
1d ago
FeaturedOriginal
After Nvidia’s $20B not-acqui-hire, AI chip startup Groq reportedly raising $650M
AI Summary
AI chip startup Groq is reportedly raising $650 million to shift its focus from hardware to AI inference, enhancing how AI models respond to prompts. This move follows Nvidia's recent $20 billion not-acqui-hire, indicating a competitive landscape in AI chip development.
